Last reviewed · How we verify
Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults
The purpose of this study is to evaluate the safety and blood levels of a medicine, naltrexone, contained within an implant in healthy volunteers age 18 to 65 years. To do this, the implant containing the drug will be inserted under the skin, left in place for 3 months and then removed.
Details
| Lead sponsor | Akyso Therapeutics, LLC |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 16 |
| Start date | Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Apr 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Opioid Use Disorder
Interventions
- BIOPIN-6 Active Implant with Naltrexone
- BIOPIN-6 Placebo Implant
Countries
United States